BLOG

US DSCSA – Saleable Returns Verification

October 7th, 2019

According to the Healthcare Distribution Alliance (HDA) which represent wholesale distributors in the U.S., every year, approximately 60 million units of pharmaceutical saleable product are returned annually as a result of overstocked or overorder of products. Returns are a complex and crucial stage in the product lifecycle. Product returns which are classified into saleable and […]

Read More

Russian Serialization & Aggregation Regulations

October 7th, 2019

The deadline is looming for manufacturers of pharmaceutical products manufactured in Russia or imported into Russia. From January 1st, 2020 they need to comply with the additional serialization and aggregation regulations for complete unit and batch level traceability. Russia is known to have one of the most stringent serialization requirements in the world, and unlike […]

Read More

8th Annual Global Pharma Regulatory Summit 2019

May 20th, 2019

Global Pharma Regulatory Summit is the ground-breaking event uniting the leading stakeholders from across the pharma ecosystem. The summit is expertly designed and curated to encourage the conversation across trends and challenges.

Read More

Statement by the Private Sector Constituency on World TB Day

May 20th, 2019

24 March 2019 — To mark World TB Day, the Stop TB Partnership Private Sector Constituency (PSC) calls attention to the devastating health, social, and economic impact of tuberculosis (TB), urges the global community to accelerate efforts to end this disease, and commits to do its part. It’s TIME!

Read More
View More...